
### [NCIT:C4074](http://purl.obolibrary.org/obo/NCIT_C4074)
**Label:** Centroblastic Lymphoma

**Subclasses:** [NCIT:C8926](http://purl.obolibrary.org/obo/NCIT_C8926) (Recurrent Centroblastic Lymphoma), [NCIT:C8927](http://purl.obolibrary.org/obo/NCIT_C8927) (Refractory Centroblastic Lymphoma), [NCIT:C7248](http://purl.obolibrary.org/obo/NCIT_C7248) (Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C8931](http://purl.obolibrary.org/obo/NCIT_C8931) (Stage IV Centroblastic Lymphoma), [NCIT:C8930](http://purl.obolibrary.org/obo/NCIT_C8930) (Stage III Centroblastic Lymphoma), [NCIT:C8928](http://purl.obolibrary.org/obo/NCIT_C8928) (Stage I Centroblastic Lymphoma), [NCIT:C8929](http://purl.obolibrary.org/obo/NCIT_C8929) (Stage II Centroblastic Lymphoma), 

**Class expressions from DL-Learner:**

- [NCIT:C36449](http://purl.obolibrary.org/obo/NCIT_C36449) (Clonal BCL6 Gene Rearrangement) 55.00%
- [NCIT:C36442](http://purl.obolibrary.org/obo/NCIT_C36442) (Clonal BCL2 Gene Rearrangement) 55.00%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and [NCIT:C36333](http://purl.obolibrary.org/obo/NCIT_C36333) (Clonal Gene Rearrangement) 55.00%
- Thing 52.57%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) 40.36%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C39588](http://purl.obolibrary.org/obo/NCIT_C39588) (Serum Soluble Fas Ligand Level Increased))) 40.36%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C39586](http://purl.obolibrary.org/obo/NCIT_C39586) (T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta))) 40.36%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C39584](http://purl.obolibrary.org/obo/NCIT_C39584) (T-Cell Large Granular Lymphocyte Leukemia, Common Variant))) 40.36%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C39583](http://purl.obolibrary.org/obo/NCIT_C39583) (FAS Apoptosis Pathway Deregulation))) 40.36%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C3958](http://purl.obolibrary.org/obo/NCIT_C3958) (Disseminated Peritoneal Leiomyomatosis))) 40.36%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C39573](http://purl.obolibrary.org/obo/NCIT_C39573) (T-Lymphocyte with a Post-Thymic Immunophenotype))) 40.36%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C39572](http://purl.obolibrary.org/obo/NCIT_C39572) (Neoplastic Cerebriform T-Prolymphocyte))) 40.36%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C39571](http://purl.obolibrary.org/obo/NCIT_C39571) (Neoplastic Small T-Prolymphocyte))) 40.36%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C39569](http://purl.obolibrary.org/obo/NCIT_C39569) (Cytoplasmic Protrusions Present))) 40.36%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C39565](http://purl.obolibrary.org/obo/NCIT_C39565) (Coarse Azurophilic Granules Present))) 40.36%


